Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies.
Kallunki P, Sotty F, Willén K, Lubas M, David L, Ambjørn M, Bergström AL, Buur L, Malik I, Nyegaard S, Eriksen TT, Krogh BO, Stavenhagen JB, Andersen KJ, Pedersen LØ, Cholak E, van den Brink EN, Rademaker R, Vink T, Satijn D, Parren PWHI, Christensen S, Olsen LR, Søderberg JN, Vergo S, Jensen A, Egebjerg J, Wulff-Larsen PG, Harndahl MN, Damlund DSM, Bjerregaard-Andersen K, Fog K.
Kallunki P, et al. Among authors: soderberg jn.
NPJ Parkinsons Dis. 2025 May 22;11(1):132. doi: 10.1038/s41531-024-00849-1.
NPJ Parkinsons Dis. 2025.
PMID: 40404755
Free PMC article.